Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Exogen Biotechnology

Exogen Biotechnology
Out of Business LATEST DEAL TYPE

Owner and operator of a company providing technologies to monitor DNA damage and to assess DNA repair capacities. The company provides services for individuals, organizations and research institutes to monitor damage to their DNA and to assess their DNA repair capacities for the purposes of personalized and preventive health care.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Other Healthcare
Primary Office
  • QB3 East Bay Innovation Center
  • 820 Heinz Avenue
  • Berkeley, CA 94710
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Exogen Biotechnology’s full profile, request a free trial.

Exogen Biotechnology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Oct-2017 Completed Out of Business
3. Product Crowdfunding 26-Mar-2014 00000 Completed Startup
2. Grant $70K Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Exogen Biotechnology Executive Team (3)

Name Title Board
Christian Keller Chief Executive Officer
Jonathan Tang Ph.D Co-Founder & Chief Technology Officer
Sylvain Costes Ph.D Co-Founder & CSO